Augmentin safety information13
Contraindications :
- In patients with a history of hypersensitivity to beta-lactams, e.g. penicillins and cephalosporins. (UAE 457 mg)
- In patients with a previous history of AUGMENTIN-associated jaundice/hepatic dysfunction. (UAE 457 mg)
- In patients with known hypersensitivity to penicillins and cephalosporins or to any ingredient of Augmentin, as well as in patients who developed jaundice or hepatic dysfunction during previous Augmentin therapy. [457mg for (Oman, Qatar, Bahrain, Kuwait), & 1gm for all 5 GCC Countries]
- Hypersensitivity to the active substances, to any of the penicillins or to any of the excipients (ES for all 5 GCC Countries & 625 mg for UAE, Oman, Qatar, Bahrain)
- History of a severe immediate hypersensitivity reaction (e.g. anaphylaxis) to another beta-lactam agent (e.g. a cephalosporin, carbapenem or monobactam). (ES for all 5 GCC Countries & 625 mg for UAE, Oman, Qatar, Bahrain)
- History of jaundice/hepatic impairment due to amoxicillin/clavulanic acid. (ES for all 5 GCC Countries & 625 mg for UAE, Oman, Qatar, Bahrain)
- Infectious mononucleosis, lymphocytic leukemia: Patients suffering from these diseases are particularly predisposed to exanthema formation during amoxicillin therapy. [457mg for (Oman, Qatar, Bahrain, Kuwait)]
- Infectious mononucleosis, lymphatic leukaemia: when treated with amoxicillin, patients with these conditions are especially predisposed to skin rashes. (1gm for all 5 GCC Countries)
Undesirable Effects:
Mucocutaneous candidiasis, Diarrhoea, Nausea, vomiting